Waystar Holding Corp.
WAY Mid CapHealthcare · Health Information Services
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Waystar Holding Corp. en bref
Waystar Holding Corp. (WAY) is currently trading at 16,10 € with a market capitalization of 3,1 Md €. The trailing P/E ratio stands at 27.57x, with a forward P/E of 10.01x. The 52-week range spans from 15,47 € to 36,15 €; the current price is 55.5% below the yearly high. Year-over-year revenue growth stands at +22.4%. The net profit margin stands at 10.9%.
💰 Dividende
Waystar Holding Corp. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
23 analystes évaluent Waystar Holding Corp. (WAY) au consensus : Achat Fort. L'objectif de cours moyen est de 29,49 €, soit un potentiel de +83.14% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 21,79 € à 38,36 €.
Waystar Holding Corp. : la thèse d'investissement en détail
Waystar Holding Corp. (WAY) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Revenue is growing at a healthy 22.4% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 37.5% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. With a gross margin near 68.72%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.
À surveiller
- The forward P/E of 10.01x is meaningfully below the trailing 27.57x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 83.14% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Forte croissance du CA de 22.4% sur un an
- Marge brute élevée de 68.72% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Strong Buy
- Bilan solide avec faible endettement (D/E 37.75)
- Free cash flow positif
Aucun signal d'alerte significatif dans les indicateurs actuels.
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to relatively defensive market behavior, elevated short interest (6.83%).
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Waystar Holding Corp.?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
